E72.53 Primary hyperoxaluria

Name of the Condition

• Primary hyperoxaluria (ICD-10 Code: E72.53)

Summary

Primary hyperoxaluria is a rare genetic disorder characterized by the overproduction of oxalate, a chemical byproduct of metabolism. This condition leads to excessive oxalate accumulation in the kidneys, urinary tract, and other tissues, increasing the risk of kidney stones, kidney damage, and systemic complications. The disorder disrupts normal oxalate metabolism, resulting in elevated levels of oxalate in the body.

Causes

Primary hyperoxaluria is caused by genetic mutations that impair enzymes involved in oxalate metabolism. These mutations disrupt the biochemical pathways responsible for breaking down glyoxylate, a precursor to oxalate, leading to its conversion into oxalate. Most cases are inherited in an autosomal recessive pattern, requiring two mutated copies of a gene for the condition to manifest.

Risk Factors

• Family history of primary hyperoxaluria.
• Consanguinity (parents who are close relatives) increasing the likelihood of inheriting recessive mutations.
• Ethnic or geographic prevalence of specific genetic variants in certain populations.

Symptoms

• Recurrent kidney stones (nephrolithiasis) or kidney stone formation.
• Hematuria (blood in urine).
• Urinary tract infections.
• Kidney pain or discomfort.
• In severe cases, kidney failure or systemic oxalosis (oxalate deposition in other organs).

Diagnosis

Diagnosis involves measuring oxalate levels in urine and blood, often showing elevated oxalate excretion. Genetic testing may confirm mutations in genes associated with oxalate metabolism. Imaging studies, such as ultrasound or CT scans, can detect kidney stones or kidney damage. Additional tests may assess kidney function and rule out other causes of hyperoxaluria.

Treatment Options

Treatment focuses on reducing oxalate production and preventing complications. This may include high fluid intake to dilute urine, medications to bind oxalate in the gut, and dietary modifications to limit oxalate intake. In severe cases, dialysis or kidney transplantation may be necessary. Emerging therapies, such as enzyme replacement or gene therapy, are under investigation.

Prognosis and Follow-Up

Prognosis varies depending on the severity and early intervention. Early diagnosis and treatment can slow disease progression and reduce complications. Regular monitoring of kidney function, oxalate levels, and stone recurrence is essential. Long-term follow-up with a nephrologist is recommended to manage symptoms and adjust treatment as needed.

Complications

• Recurrent kidney stones leading to obstruction or infection.
• Chronic kidney disease or kidney failure.
• Oxalosis, with oxalate deposition in bones, heart, or other organs.
• Increased risk of urinary tract infections.

Lifestyle & Prevention

• Maintain high fluid intake to reduce urine concentration and oxalate crystallization.
• Follow a low-oxalate diet, avoiding foods like spinach, nuts, and chocolate.
• Monitor and manage kidney stone risk factors, such as dehydration or dietary oxalate.
• Avoid supplements containing vitamin C, which can increase oxalate production.

When to Seek Professional Help

Seek medical attention if you experience severe kidney pain, blood in urine, recurrent urinary tract infections, or signs of kidney failure (e.g., swelling, fatigue, reduced urine output). Prompt evaluation is critical to prevent irreversible kidney damage.

Tips for Medical Coders

Document the presence of genetic testing results, oxalate levels, and clinical manifestations (e.g., kidney stones, kidney failure) to support the diagnosis. Ensure coding aligns with the specific subtype of primary hyperoxaluria, as documentation may specify enzyme deficiencies or genetic mutations. Verify that the code E72.53 is used for primary hyperoxaluria and not secondary causes of hyperoxaluria.